Austin N Kirschner
Overview
Explore the profile of Austin N Kirschner including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
498
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rajkumar-Calkins A, Sagar V, Wang J, Bailey S, Anderson P, Abdulkadir S, et al.
Radiother Oncol
. 2025 Feb;
206:110794.
PMID: 39978680
Purpose: PIM kinases are associated with treatment resistance and poor prognosis in prostate cancer through roles in DNA damage response, cellular metabolism, proliferation, and survival. We hypothesized PIM inhibition addresses...
2.
McComas K, Luo G, Ding G, Martinez S, Price M, Kirschner A
Phys Med
. 2024 Nov;
128:104858.
PMID: 39520732
Background: Stereotactic radiosurgery (SRS) is an effective treatment for essential tremor (ET) and Parkinsonian tremor (PT). However, current treatment methods can be time-consuming and expose patients to unnecessary radiation. This...
3.
Smelser W, Wang J, Ogden K, Chang S, Kirschner A
BJU Int
. 2023 Mar;
132(3):298-306.
PMID: 36961272
Objectives: To test if intravesical instillation of both an anti-programmed cell death protein 1 (PD-1) inhibitor and an oncolytic reovirus would demonstrate a greater effect than either treatment alone, as...
4.
Dove A, Wells A, Gong W, Liu D, Kirschner A
Am J Clin Oncol
. 2022 Nov;
45(12):501-505.
PMID: 36413679
Objectives: The best fractionation for stereotactic body radiotherapy (SBRT) in renal cell carcinoma (RCC) metastases has not been well defined. In addition, the literature on outcomes using 5-fraction SBRT in...
5.
Kessler M, Dove A, Kirschner A
Cureus
. 2022 Oct;
14(9):e28925.
PMID: 36237749
Radiation-induced fibrosis is a potentially severe late complication after high-dose radiotherapy. Over the last decade, there has been increasing use of stereotactic body radiation therapy (SBRT) to treat both primary...
6.
Dove A, Jaboin J, Block J, Shinohara E, Kirschner A
J Med Imaging Radiat Sci
. 2022 Oct;
53(4):659-663.
PMID: 36216733
Objective: Currently, there are no consensus guidelines about handling incidental radiological findings on radiotherapy planning CT simulation scans. Retrospective studies analyzing incidental findings on CT simulations show a small, but...
7.
Devan S, Jiang X, Kang H, Luo G, Xie J, Zu Z, et al.
Magn Reson Imaging
. 2022 Oct;
94:144-150.
PMID: 36209946
Background: It remains a clinical challenge to differentiate brain tumors from radiation-induced necrosis in the brain. Despite significant improvements, no single MRI method has been validated adequately in the clinical...
8.
Ridge N, Rajkumar-Calkins A, Dudzinski S, Kirschner A, Newman N
Adv Radiat Oncol
. 2022 Sep;
7(5):100936.
PMID: 36148374
Immune checkpoint inhibitors (ICIs) have transformed the treatment paradigms for multiple cancers. However, ICI therapy often fails to generate measurable and sustained antitumor responses, and clinically meaningful benefits remain limited...
9.
Devan S, Luo G, Jiang X, Xie J, Dean D, Johnson L, et al.
Adv Radiat Oncol
. 2022 Sep;
7(6):101014.
PMID: 36060637
Purpose: Our purpose was to develop a rodent model of brain radionecrosis using clinical linear accelerator based stereotactic radiosurgery. Methods And Materials: Single fraction maximum prescription points in the mouse's...
10.
Devan S, Jiang X, Luo G, Xie J, Quirk J, Engelbach J, et al.
Cancer Res
. 2022 Jul;
82(19):3603-3613.
PMID: 35877201
Significance: This work introduces and provides preclinical validation of a new diffusion MRI method that exploits intrinsic differences in cell sizes to distinguish brain tumors and radiotherapy necrosis.